Beranda › Penyakit Paru Interstisial › Michigan › Ann Arbor
Uji klinis Penyakit Paru Interstisial di Ann Arbor, MI
11 studi untuk Penyakit Paru Interstisial mencari peserta di lokasi sekitar Ann Arbor (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Menerima pesertaFase 3
- University of Michigan, Ann Arbor
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Menerima pesertaFase 3
- University of Michigan, Ann Arbor
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Menerima pesertaFase 2/3
- GSK Investigational Site, Ann Arbor
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Menerima peserta
- University of Michigan - Michigan Medicine, Ann Arbor
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Menerima pesertaFase 2
- Clinical Research Site, Ann Arbor
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Menerima pesertaStudi observasional
- University of Michigan, Ann Arbor
Platform Clinical Study for Conquering Scleroderma
Menerima pesertaFase 2
- University of Michigan, Ann Arbor
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Menerima pesertaFase 2/3
- University of Michigan, Ann Arbor
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Menerima pesertaFase 2
- University of Michigan, Ann Arbor
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
Menerima pesertaFase 2
- Galderma Investigational Site # 8743, Ann Arbor
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
Menerima pesertaStudi observasional
- University of Michigan, Ann Arbor
Uji klinis Penyakit Paru Interstisial di kota lain
- New York City, NY18 studi
- Philadelphia, PA16 studi
- Los Angeles, CA14 studi
- Kansas City, KS13 studi
- Durham, NC13 studi
- Charleston, SC13 studi
- Chicago, IL12 studi
- Houston, TX12 studi
- Aurora, CO11 studi
- Phoenix, AZ9 studi
- Salt Lake City, UT9 studi
- Boston, MA9 studi
Studi lain di Ann Arbor
- Kanker Prostat27 studi
- Kanker Payudara26 studi
- Kanker Paru Non-Sel Kecil26 studi
- Kanker (semua jenis)25 studi
- Kanker Kolorektal23 studi
- Kanker Paru23 studi
- Gagal Jantung22 studi
- Leukemia Mieloid Akut17 studi
- Penyakit Kardiovaskular16 studi
- Kanker Pankreas14 studi
- Melanoma12 studi
- Kanker Ginjal (Karsinoma Sel Renal)12 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.